NCI’s Alliance for Nanotechnology in Cancer – Lessons Learned and Plans for Phase 2 | |
| Piotr GrodzinskiDirector of Nanotechnology for CancerNCI’s Alliance for Nanotechnology in Cancer |
Dr. Piotr Grodzinski is a Director of Nanotechnology for Cancer programs at NCI. He coordinates program and research activities of the Alliance for Nanotechnology in Cancer which has dedicated $144M over 5 years (2004?2009). These funds have supported the formation of interdisciplinary centers as well as individual research and training programs targeting nanotechnology solutions for improved prevention, detection, and treatment of cancer.
Dr. Grodzinski is a materials scientist by training, but found bio- and nanotechnology fascinating. In the mid-nineties, he left the world of semiconductor research and built a large microfluidics program at Motorola Corporate Research & Development in Arizona. The group made important contributions to the development of integrated microfluidics for genetic sample preparation with its work being featured in Chemical & Engineering News and Nature Reviews. After his tenure at Motorola, Dr. Grodzinski joined the Bioscience Division of Los Alamos National Laboratory where he served as a Group Leader and an interim Chief Scientist for the Department of Energy Center for Integrated Nanotechnologies (CINT).
Dr. Grodzinski received his Ph.D. in Materials Science from the University of Southern California, Los Angeles in 1992. He is an inventor on 15 patents and has authored over 100 technical publications and conference presentations.
Dr. Grodzinski has been an invited speaker and has served on the committees of numerous bio- and nano-Micro-Electromechanical Systems conferences.
